logo BDSP

Base documentaire


Votre avis nous intéresse

Le réseau BDSP met en oeuvre un projet d'innovation et d'amélioration de ses services, dans le souci constant de proposer des contenus de qualité adaptés aux besoins des utilisateurs.

Identifier de nouvelles sources de financements est la condition nécessaire pour assurer la poursuite et la pérennité de cet outil unique qu'est la BDSP, tout en le faisant évoluer.

Pour définir un nouveau modèle économique, nous avons besoin de votre avis : merci de répondre à notre enquête (temps estimé : 5 minutes).

Participer maintenant
Participer plus tard J'ai déjà participé

  1. Results of an epidemiological study on drug-treated intraocular hypertension in Belgium.

    Article - En anglais

    Some epidemiological aspects of drug-treated intraocular hypertension in Belgium were established in 1992 from questionnaires filled in by 1513 patients who attended a sample of 209 pharmacies open to the public.

    The mean age of the patients was 67 years (range : 3-95).

    After standardization for age, the prevalence of diabetes mellitus among patients was found to be 1.7 times higher than in the general population.

    Family history of glaucoma and/or blindness was reported by 28% of the patients.

    Beta-blocker eye drops were used by 96% of the sample.

    An ophthalmologist was consulted more than four times a year by 24% of the patients who had been drug-treated for less than one year ; the proportion, however, decreases to 11% for those treated for at least five years.

    The annual consumed dose of eye drops containing parasympathomimetics, beta-blockers, and epinephrine or dipivefrine was 12.4,13.6, and 12.3 bottles, respectively, and that of ointments containing parasympathomimetics was 9.9 tubes.

    From these results and using sales figures, the prevalence of drug-treated intraocular hypertension was found to be 77 per 10,000 inhabitants (95% CI : 31-123).

    Mots-clés Pascal : Glaucome, Tonus oculaire, Médicament, Parasympathomimétique, Bloquant bêta-adrénergique, Adrénaline, Dipivéfrine, Epidémiologie, Toxicité, Homme, Belgique, Europe, Oeil pathologie

    Mots-clés Pascal anglais : Glaucoma (eye), Intraocular pressure, Drug, Parasympathomimetic, Beta blocking agent, Epinephrine, Epidemiology, Toxicity, Human, Belgium, Europe, Eye disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 96-0420260

    Code Inist : 002B02U09. Création : 10/04/1997.